相关实验视频

Updated: May 28, 2025

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

对接受加速Epi-on原蛋白交叉连接的患者进行了6个月的随访

Alina-Cristina Chiraples¹, Diana Maria Darabus¹, Horia Tudor Stanca²

¹Department of Ophthalmology, "Victor Babeş" University of Medicine and Pharmacy, Timişoara, Romania.

Romanian journal of ophthalmology

|February 12, 2025

概括

加快原交叉连接 (A-CXL) 改善了角膜曲率和减少角膜曲率在角质患者. 角膜厚度在治疗后增加,在六个月后观察到轻微的地形变化.

科学领域:

眼科医生眼科眼科
角膜外科手术角膜外科手术
视觉科学视觉科学视觉科学

背景情况:

角膜是一种渐进的角膜脱光,导致视力受损.
加速原交叉连接 (A-CXL) 是一种快速的,最少的侵入性治疗.

研究的目的:

在加速原交叉连接 (A-CXL) 后六个月,评估视觉敏度和角膜地形的变化.

主要方法:

从20名接受A-CXL治疗的角质患者30只眼睛的回顾性分析.
视力敏度,折射误差和地形参数 (Kmax,SIf,SIb,KVf,KVb,BCVf,BCVb,TCT,CCT) 在处理前后进行比较.

主要成果:

最好的校正视敏度 (BCVA) 在A-CXL后得到改善.
气透镜和Kmax值下降. 气透镜和Kmax值下降. 气透镜和Kmax值下降.
中部角膜厚度 (CCT) 和最薄角膜厚度 (TCT) 增加.

结论:

A-CXL提供了快速的视力敏度改善和减少角膜曲率在角质.
虽然角膜厚度增加了,但特定的地形标记在六个月后显示出轻微的,非统计学意义上的变化.
该程序的好处包括持续时间短,侵袭性最小,以及重新干预的可能性.

关键词:

A-CXL = 加速的原交叉连接 BCVA = 最好的校正视力敏度 CCT = 中部角膜厚度 TCT-最薄的角膜厚度 UCVA = 未经纠正的视力敏度加快的Epi-on交叉连接地形学地形学地形学视力敏度视力敏度视力敏度

更多相关视频

Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration

Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration

Published on: September 29, 2018

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...